Literature DB >> 35022271

A Recombinant Ig Fragment (IgCw-γεκ) Comprising the Cγ1-Cε2-4 and Cκ Domains Is an Alternative Reagent to Human IgE.

Minjae Kim1, Jeonghyun Lee2, Juho Choi2, Youngsil Seo1, Gyeseo Park2, Jinah Jeon2, Yerin Jeon2, Mi-Gi Lee3, Myung-Hee Kwon4,2.   

Abstract

Human IgE is useful for immunological assays, such as sensitization of FcεRI-positive cells and IgE measurement. In this study, we report the development of a recombinant Ig fragment, designated IgCw-γεκ, as an alternative reagent to human IgE. IgCw-γεκ (∼130 kDa) comprises two hybrid constant H chain regions (Cγ1-Cε2-4, each ∼53 kDa) and two constant κ L chains (Cκ, each ∼12 kDa) and lacks a V domain. The presence of Cγ1 instead of Cε1 within the H chain increased the production yield and facilitated assembly of the H and L chains. IgCw-γεκ was produced in cultured human embryonic kidney 293F cells, with a yield of ∼27 mg/l. IgCw-γεκ bound to human FcεRIαRs expressed on the surface of rat basophilic leukemia-2H3 cells. A β-hexosaminidase release assay revealed that the biological activity of IgCw-γεκ was comparable with that of IgE. The IgE concentration measured using IgCw-γεκ as a standard was similar to that measured using IgE as a standard. These results suggest that the IgCw-γεκ molecule retains the basic characteristics of IgE, but does not cross-react with Ags, making it an alternative to the IgE isotype references used in a variety of immunological assays.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35022271      PMCID: PMC8802548          DOI: 10.4049/jimmunol.2100576

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  The regulation of immunoglobulin E class-switch recombination.

Authors:  Raif S Geha; Haifa H Jabara; Scott R Brodeur
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

2.  Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a recombinant human epsilon-chain fragment of 76 amino acids.

Authors:  B Helm; D Kebo; D Vercelli; M M Glovsky; H Gould; K Ishizaka; R Geha; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Inhibition of the Prausnitz-Küstner reaction by an immunoglobulin epsilon-chain fragment synthesized in E. coli.

Authors:  R S Geha; B Helm; H Gould
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

Review 4.  IgE-associated allergic disorders: recent advances in etiology, diagnosis, and treatment.

Authors:  F Zellweger; A Eggel
Journal:  Allergy       Date:  2016-12       Impact factor: 13.146

Review 5.  How antibodies fold.

Authors:  Matthias J Feige; Linda M Hendershot; Johannes Buchner
Journal:  Trends Biochem Sci       Date:  2009-12-21       Impact factor: 13.807

Review 6.  Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases.

Authors:  Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2016-06       Impact factor: 10.793

7.  IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design.

Authors:  Chloe L Stoyle; Paul E Stephens; David P Humphreys; Sam Heywood; Katharine Cain; Neil J Bulleid
Journal:  Biochem J       Date:  2017-09-07       Impact factor: 3.857

8.  Assembly and Folding Properties of Cytosolic IgG Intrabodies.

Authors:  Youngsil Seo; Yeonjin Lee; Minjae Kim; Hyunjoon Park; Myung-Hee Kwon
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

Review 9.  An update on the hyper-IgE syndromes.

Authors:  Patrick F K Yong; Alexandra F Freeman; Karin R Engelhardt; Steven Holland; Jennifer M Puck; Bodo Grimbacher
Journal:  Arthritis Res Ther       Date:  2012-11-30       Impact factor: 5.156

10.  A tool kit for rapid cloning and expression of recombinant antibodies.

Authors:  Tihomir S Dodev; Panagiotis Karagiannis; Amy E Gilbert; Debra H Josephs; Holly Bowen; Louisa K James; Heather J Bax; Rebecca Beavil; Marie O Pang; Hannah J Gould; Sophia N Karagiannis; Andrew J Beavil
Journal:  Sci Rep       Date:  2014-07-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.